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Introduction
• Spaceflight is associated with many factors which may 
promote urinary retention, urinary tract infection, kidney 
stone formation 
• Obstructive (anatomical) – e.g., BPH
• Psychosocial
• Gravitational
• Pharmacologic
• Neurogenic (SAS-Related)
• Infectious (UTI)
• Urinary conditions are among the top 3 conditions predicted 
by NASA’s Integrated Medical Model as the most likely 
reason for emergent medical evacuation from ISS
• Kidney stone: #2
• Sepsis (urosepsis as primary driver): #3 3
Methods
• Inflight and post-flight medical records of NASA 
astronauts were reviewed for urinary retention, urinary 
tract infection, and kidney stones during Mercury, 
Gemini, Apollo, Mir, Shuttle, and ISS Expeditions 1-38
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Results – Kidney Stones
• No inflight occurrence of kidney stones
• 7 events(N=6) of kidney stones developed in the 12 
months after flight
• One case in the first 90 days after flight
• Three cases occurred within 90 to 180 days after 
landing
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Results – Urinary Retention
• 9 cases of urinary retention documented
• 16 total if symptoms suggestive of urinary retention are 
included (0.018 events per person-mission)
Shuttle ISS
Catheter
Required EVA Related
SMS Med 
Usage
Urinary Retention 8 1 4 1 7
Bladder 
fullness/pressure
2 0 0 0 1
Difficulty 
initiating/hesitancy
5 0 0 1 4
TOTAL 15 1 4 2 12
N Average Age (±SD)
Total 16 43.44 (6.62)
M 9 46.00 (7.50)
F 7 40.14 (3.48)
Urinary Retention Incidence Rates
Shuttle 0.019 events/person mission
ISS 0.021 events/person mission
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Contributing Factors 
• Incidence of space motion sickness (SMS) starting with 
Apollo range from 35-80%. 1-4Anticholinergics are a 
common treatment for SMS; i.e., Promethazine, 
Scopolamine, Meclizine (both prophylactic and active 
treatment)
• Decongestants/Antihistamines are frequently used for 
treatment on ISS, prophylactically for EVAs and for 
active treatment of upper respiratory infections/allergic 
rhinitis5
• Urinary retention is a known side effect of 
anticholinergics/anticholinergic-like medication
1Nicogossian et al  Space Physiology and Medicine 3rd ed, 2Reschke et al  Space 
Biology and Medicine , 3Davis et al ASEM March 1993, 4Jennings J Vestib Res 1998,
5Wotring FASEB J. 2015
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Results – Urinary Retention
Odds of developing urinary retention are 3 times higher among 
astronauts who took promethazine.
Females are 4 times more likely to develop urinary retention than 
males
P<0.00011,2 Incidence Rate 95% Confidence Limits
Promethazine 0.032 0.0165 0.0612
None 0.0108 0.0044 0.0265
P=0.01611,2 Incidence Rate 95% Confidence Limits
Males 0.0128 0.0058 0.0280
Females 0.0546 0.0226 0.01261
1Based on Shuttle US and IP crewmembers and ISS US crewmembers
2Adjusted for repeated individuals
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Results – Urinary Tract Infection
• All Shuttle crewmembers and/ ISS US crewmembers: 9 
cases
• Male: 1 event
• Female: 8 events (5 crewmembers)
• Other publically known events of UTI in males in space 
flight
• Apollo
• Early Russian Mir
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Urinary Tract Infection
• Report of two Shuttle flights of a crewmember with 
positive urine culture for Escherichia coli at landing
• Both cases had bladder catheterizations inflight
• First case prophylaxed with antibiotics at time of bladder cath
• Switched to TMP/SMX DS after exhausted supply of nitrofurantoin
• Ground culture later found to be resistant to TMP/SMX DS
• Second case received antibiotic prophylaxis and still had 
bacteriuria at landing
Stepaniak PC, Ramchandani, SR, Jones, JA.  Acute Urinary Retention Among 
Astronauts.  Aviation, Space, and Environmental Medicine. April 2007;78,4: A5-8
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Urinary Retention and 
Urinary Tract Infection
Events N=
Only Urinary Retention 12 10
Only Urinary Tract Infection 5 5
Urinary Retention + Urinary Tract Infection 4 3
Total Events 21 15
Urinary Retention Urinary Tract Infection
12 54
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• An astronaut with urinary retention is 25x more likely to have a UTI
• 17% infection rate
• Urinary retention vs. UTI - which is the chicken and which is the egg?
• An astronaut with a bladder cath is 2.5x more likely to have a UTI (not 
statistically significant; not enough cases to have adequate power)
• 42% infection rate
• Includes cases that prophylaxed with antibiotics
Urinary Retention and UTI
Based on all crewP<0.0001 Infection Rate 95% Confidence Limits
Retention 0.1679 0.0619 0.3818
No retention 0.0067 0.0028 0.0159
P=0.4412 Infection Rate 95% Confidence Limits
Cath 0.4218 0.0178 0.9670
No cath 0.1746 0.0149 0.7472
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• It is unclear if spaceflight carries an increased postflight risk of 
kidney stones.
• Urinary retention
• Female to male odds ratio is higher inflight compared to the general 
population where older males comprise almost all cases due to prostatic 
hypertrophy
• The higher prevalence in females is even more concerning given the fact 
that there have been many more males in space than females 
• Promethazine use increases the risk of developing urinary 
retention in spaceflight
• Urinary retention and urinary tract infection are highly associated
• Both with or without bladder catheterization, but catheterization further 
increases risk of infection
Discussion
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• Urinary retention is a bigger issue than previously thought
• Standard treatment for urinary retention (cath) increases risk of 
UTI
• Aseptic techniques can be especially challenging with an inexperienced 
provider in a free-floating environment
• Consider using touch free catheter systems to reduce infections
• UTIs treated with antibiotics
• Medication supplies can become depleted
• Exploration mission shelf live issues and potentially decreased antibiotic 
effectiveness
• Potential for bacterial resistance
• Theoretical increased pathogen virulence 
• Altered immune function
• Inadequately treated UTI may lead to pyelonephritis and sepsis 
evacuation or mission impact
• Inflight urinary retention and UTI have proven to be 
associated and their risks should be considered collectively 
when planning for spaceflight.
So What?
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Backup
• Urinary retention in men becomes more common with age.
• In men 40 to 83 years old, the overall incidence of urinary retention is 4.5 to 
6.8 per 1,000 men.
• For men in their 70s, the overall incidence increases to 100 per 1,000 men.
• For men in their 80s, the incidence of acute urinary retention is 300 per 1,000 
men.
• Urinary retention in women is less common, though not rare.
• The incidence of urinary retention in women has not been well 
studied because researchers have primarily thought of urinary 
retention as a male problem related to the prostate.
NIH, http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/urinary-
retention/Pages/facts.aspx
Terrestrial Data on Urinary Retention
